GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Malaysian Genomics Resource Centre Bhd (XKLS:0155) » Definitions » 3-Year EBITDA Growth Rate

Malaysian Genomics Resource Centre Bhd (XKLS:0155) 3-Year EBITDA Growth Rate : 20.60% (As of Mar. 2025)


View and export this data going back to 2010. Start your Free Trial

What is Malaysian Genomics Resource Centre Bhd 3-Year EBITDA Growth Rate?

Malaysian Genomics Resource Centre Bhd's EBITDA per Share for the three months ended in Mar. 2025 was RM-0.00.

During the past 3 years, the average EBITDA Per Share Growth Rate was 20.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Malaysian Genomics Resource Centre Bhd was 20.60% per year. The lowest was -17.40% per year. And the median was 1.60% per year.


Competitive Comparison of Malaysian Genomics Resource Centre Bhd's 3-Year EBITDA Growth Rate

For the Diagnostics & Research subindustry, Malaysian Genomics Resource Centre Bhd's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Malaysian Genomics Resource Centre Bhd's 3-Year EBITDA Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Malaysian Genomics Resource Centre Bhd's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Malaysian Genomics Resource Centre Bhd's 3-Year EBITDA Growth Rate falls into.


;
;

Malaysian Genomics Resource Centre Bhd 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Malaysian Genomics Resource Centre Bhd  (XKLS:0155) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Malaysian Genomics Resource Centre Bhd 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Malaysian Genomics Resource Centre Bhd's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Malaysian Genomics Resource Centre Bhd Business Description

Traded in Other Exchanges
N/A
Address
Jalan Teknologi 3/6, 8F, Taman Sains Selangor 1, Kota Damansara (PJU5), Petaling Jaya, SGR, MYS, 47810
Malaysian Genomics Resource Centre Bhd is a Malaysia-based company. The company's principal activities include enabling personalized and precision medicine through genetics, genomics, immunotherapy, and biopharmaceutical services, as well as investment holding. It offers genome sequencing and analysis (GSA) services and genetic screening services (GSS). GSA services involve the sequencing and analysis of the DNA of humans, animals, plants, and microbes for biological information. The company provides GSS services through its range of genetic screening tests under the brand Dtect, which screens human DNA for genetic markers related to diseases and health conditions. It is also engaged in Research, development, and distribution of biopharmaceutical products and services.

Malaysian Genomics Resource Centre Bhd Headlines

No Headlines